Cigna Corporation (NYSE:CI) Chairman Isaiah Harris, Jr. sold 247 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cigna Corporation (NYSE CI) traded up 0.44% during midday trading on Friday, hitting $186.05. 2,462,011 shares of the stock traded hands. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $188.36. The firm has a market cap of $46.84 billion, a P/E ratio of 21.47 and a beta of 0.43. The company’s 50-day moving average is $179.52 and its 200 day moving average is $165.10.

Cigna Corporation (NYSE:CI) last issued its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.98 earnings per share. On average, analysts anticipate that Cigna Corporation will post $10.02 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2017/09/17/cigna-corporation-ci-chairman-sells-45761-69-in-stock.html.

CI has been the subject of a number of research analyst reports. UBS AG reiterated a “buy” rating and set a $186.00 price objective (up previously from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. Bank of America Corporation lifted their price objective on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a report on Friday, June 23rd. Jefferies Group LLC reiterated a “buy” rating and set a $183.00 price objective on shares of Cigna Corporation in a report on Thursday, June 8th. ValuEngine lowered shares of Cigna Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 20th. Finally, Citigroup Inc. lifted their price objective on shares of Cigna Corporation from $185.00 to $198.00 and gave the company a “buy” rating in a report on Monday, August 7th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $182.59.

Several institutional investors and hedge funds have recently modified their holdings of CI. BlackRock Inc. raised its holdings in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after acquiring an additional 16,289,943 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Cigna Corporation by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after acquiring an additional 1,184,632 shares in the last quarter. Waddell & Reed Financial Inc. raised its holdings in Cigna Corporation by 125.8% in the first quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock valued at $256,306,000 after acquiring an additional 974,747 shares in the last quarter. Wellington Management Group LLP raised its holdings in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after acquiring an additional 913,991 shares in the last quarter. Finally, Thrivent Financial For Lutherans raised its holdings in Cigna Corporation by 7,868.4% in the first quarter. Thrivent Financial For Lutherans now owns 708,390 shares of the health services provider’s stock valued at $103,772,000 after acquiring an additional 699,500 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.